chevron_leftBack
As of 14 June 2026, MFC Co., Ltd. has a market cap of $20.2M USD, ranking #37004 globally and #2345 in South Korea.
It ranks #3315 in the Healthcare sector, and #1108 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$20.2MUSD
30.72B KRW
Enterprise Value
$16.83MUSD
25.55B KRW
Revenue (TTM)
$13.68MUSD
20.8B KRW
EBITDA (TTM)
$887.61KUSD
1.35B KRW
Net Income (TTM)
$540.41KUSD
821.87M KRW
EBITDA Margin
6.5%
Profit Margin
4%
PE Ratio
115.3
PS Ratio
1.5
PB Ratio
1.0
EV/EBITDA
19.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
Founded
2008
Website
mfcglobal.co.kr
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.4% | -2.6% | 2.6% | -0.1% | -6.5% | -14% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
432980
엠에프씨(주)
ISIN: KR7432980001
Shares Out.:
Shares Outstanding:
8.076M1
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
3,560 KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About MFC Co., Ltd.
MFC Co., Ltd. operates as a pharmaceutical company in South Korea. The company specializes in research and development of pharmaceuticals; and provides materials and active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and manufacturing services. MFC Co., Ltd. was founded in 2008 and is based in Hwaseong-si, South Korea.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
KRX: 0126Z0
|
$9.15B
45K%
13.91T KRW
|
-
|
|
KRX: 000250
|
$6.77B
33K%
10.3T KRW
|
1958.1
|
|
KRX: 326030
|
$5.24B
26K%
7.97T KRW
|
29.9
|
|
KRX: 298380
|
$4.96B
24K%
7.55T KRW
|
-
|
|
KRX: 000100
|
$4.55B
22K%
6.92T KRW
|
35.9
|
|
KRX: 141080
|
$4.44B
22K%
6.76T KRW
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
4M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
3M%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
2M%
|
97.4
|
|
SIX: RO
|
$321.52B
2M%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
1M%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
1M%
218.9B CHF
|
20.5
|
chevron_leftBack